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Toxoplasma gondii metabolism
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Metabolic enzymes do not operate in isolation 
rather they form components of an integrated 
biochemical network. To acquire a more complete 
understanding of the complex relationships 
between enzymes and pathways, constraints 
based modeling frameworks such as flux balance 
analysis (FBA) have been developed.
Here we present an extensively ‘curated’ genome 
scale metabolic reconstruction (iCS352) for 
Toxoplasma gondii, which includes 470 metabolic 
and transport reactions. Three hundred and seventy 
three reactions could be accounted for by 352 
genes. The remaining reactions represent either 
experimentally verified reactions in T. gondii for 
which no gene has yet been identified or reactions 
predicted to be essential for parasite growth. 
An objective function based on current literature 
and optimized by FBA simulations was formulated 
to describe the biomass constituents required for 
growth. Using available microarray data, reaction 
constraints were introduced to reflect the relative 
expression of each enzyme. FBA was performed 
to monitor the effects of gene deletions in six 
different strains (Me49, CTG, RH1, GT1, VEG and 
Prugniaud). 
Applied to T. gondii Me49, our studies predict 
224 essential reactions that represent potential 
targets for therapeutic intervention. Across the six 
strains we identified nine reactions whose deletions 
had variable impact on parasite growth and are 
predicted to mediate critical roles in virulence. Flux 
variability analysis also revealed changes in flux 
limits across the six strains, suggesting reliance on 
alternate pathways. 
Based on these analyses, we have begun 
targeting enzymes in the pantothenate biosynthesis 
pathway for further biochemical characterization 
and in vivo knockout studies in Toxoplasma.
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Toxoplasma gondii is an obligate intracellular 
parasite from the phylum Apicomplexa with 
worldwide distribution. Infections are usually 
asymptomatic; however life-threatening illness 
occurs in immunocompromised patients and in the 
fetus (1). Current drugs cause severe side effects 
in some patients, and are not effective against the 
latent stage of the parasite (2). Thus, there is a 
need to identify new targets for the design of less 
toxic and more effective drugs. 
Targeted gene disruption experiments 
demonstrate that the pyrimidine biosynthetic 
pathway of T. gondii is essential for parasite 
replication and virulence, and its enzymes are 
potential drug targets (3,4). Bioinformatic analyses 
suggest that structural differences between T. 
gondii and human enzymes may be exploited to 
produce parasite-specific inhibitors. 
Our lab has cloned, overexpressed, and purified 
the following pyrimidine biosynthetic enzymes from 
T. gondii: aspartate transcarbamoylase (catalyzing 
step 2 of the pathway), dihydroorotase (step 3), 
dihydroorotate dehydrogenase (step 4), orotate 
phosphoribosyl transferase (step 5), orotidine-5’-
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monophosphate decarboxylase decarboxylase (step 
6), and cytidine triphosphate synthase (step 8).
Our goal is to use these active recombinant 
enzymes to test potential inhibitors, and to develop 
a full strategy against the entire pathway. Various 
sources of inhibitors are being used, including 
the National Cancer Institute Chemotherapeutic 
Agents Repository, and inhibitors of Plasmodium 
pyrimidine biosynthetic enzymes donated by other 
laboratories. 
Kinetic parameters have been determined for four 
of the purified recombinant proteins, and inhibitor 
studies are in progress. Kinetic characterizations 
of the remaining enzymes are expected shortly. To 
complement the in vitro inhibitor studies, we have 
generated models of the T. gondii enzymes based 
on structures of enzymes from other organisms 
for use in in silico docking experiments. Testing of 
promising inhibitors in T. gondii cultures is planned. 
The availability of active recombinant proteins 
makes possible future crystallization experiments 
of selected enzymes that may lead to collaborative 
structure determinations.
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Toxoplasma uses a novel nutrient pathway to internalize and 
degrade host-derived proteins
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As an obligate intracellular parasite, Toxoplasma 
sp. critically relies on the acquisition of host 
metabolites as nutrients to support its replication. 
Although it was reported that Toxoplasma sp. 
parasites adopt several strategies to usurp simple 
metabolites and lipids from host cells, none of 
these existing pathways readily permit access to 
host derived polypeptides as a nutrient source. 
While recent studies showed that Toxoplasma sp. 
cathepsin L protease (TgCPL) plays a specialized 
role as a maturase for secretory proteins, whether 
it functions in a more classic role as a resident 
catabolic enzyme in the lysosome-like compartment 
(VAC/PLV) remains unknown. 
Here, we show that a TgCPL-deficient mutant 
replicates slowly, possibly reflecting a defect in 
acquiring and/or utilizing host nutrients. Consistent 
with this, we identified host cytosolic GFP within the 
VAC/PLV of TgCPL-deficient parasites, suggesting 
that the parasite can internalize host polypeptides. 
Interestingly, host cytosolic GFP was not seen 
inside WT parasites. 
Since cathepsins such as TgCPL are classically 
associated with protein degradation, we suggest 
that the failure to detect GFP in WT parasites is 
because TgCPL and possibly other endosomal 
proteases rapidly digest it. Host ER-derived GFP 
was not detected within WT or TgCPL-deficient 
parasites, indicating either that it is not internalized 
or is below the level of detection. Moreover, we 
provide evidence of at least two additional proteases 
in the parasite endosomal system that might also 
contribute to host protein degradation. 
Mutants deficient in the known nutrient pathways 
and the parasite endocytic pathway are being 
used to dissect the mechanism of internalization 
and trafficking. Comprehensive characterization of 
host cell protein uptake by the parasite endocytic 
pathway should inform how other metabolites are 
assimilated by Toxoplasma sp. parasites, which will 
pave the way for attenuating parasite replication.
• • •  
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Toxoplasma’s great escape: regulation of a pore forming 
protein for rapid parasite
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The opportunistic pathogen Toxoplasma gondii 
secretes an arsenal of proteins to actively invade and 
exit host cells. While most characterized secretory 
proteins function in cell invasion, we discovered that 
a secreted perforin-like protein (PLP1) is essential 
for rapid host cell egress, revealing a mechanism 
for cytolytic exit. PLP1-deficient parasites are 
profoundly virulence attenuated, underscoring a 
relationship between pathogenicity and egress 
capacity.
Our recent findings suggest that PLP1 uses pH 
and membrane receptor availability to selectively 
destroy host membranes during egress while 
limiting damage to itself and the host cell during 
subsequent cell invasion. Low pH boosts PLP1 
cytolytic activity, implying a means of environmental 
regulation within the parasitophorous vacuole 
during egress. 
The parasite appears to also exploit a specific 
type of phosphatidyl inositol that is exposed on 
the internal leaflet of the host plasma membrane 
to selectively destroy this barrier to the parasite’s 
freedom. PLP1 membrane specificity is also 
dictated by cholesterol, which is minimal in the 
parasite plasma membrane, suggesting a means 
of self-protection from PLP1 cytolysis. 
Together, our findings reveal novel mechanisms 
that regulate parasite cytolytic egress from an 
expiring cell without compromising parasite integrity 
or invasion of the next target cell.
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